Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase src'

Search results for: 'research area tyrosine kinase src'

Items 1-10 of 23

Page
per page
  1. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  2. TG101209
    A4145 TG101209
    Summary: JAK2/3 inhibitor
      ≥25.5 mg/mL
  3. JAK2 Inhibitor V, Z3
    A3514 JAK2 Inhibitor V, Z3
    Summary: Jak2 tyrosine kinase inhibitor
      Soluble in DMSO or ethanol
  4. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  5. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL
  6. SD 1008
    A4515 SD 1008
    Summary: Inhibitor of JAK2/STAT3 signaling pathway,apoptosis inducer
      <32.94 mg/mL
  7. WHI-P97
    A3936 WHI-P97
    Summary: Janus kinase (JAK)-3 inhibitor
      Soluble in DMSO
  8. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  9. WHI-P154
    A4150 WHI-P154
    Target: VEGFR|Src|EGFR|JAK
    Summary: JAK3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥125.6 mg/mL
  10. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL

Items 1-10 of 23

Page
per page